Page 20 - Logix Smart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article SALT LAKE CITY, May 13, 2021 /PRNewswire/ -- Co-Diagnostics, Inc.  (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today financial results for the first quarter ended March 31, 2021. First-Quarter 2021 Financial Results: Strong quarterly results highlighted by revenue of $20.0 million, pre-tax income of $9.9 million, diluted EPS of $0.26 Revenue of $20.0 million, primarily due to sales of the Logix Smart™ COVID-19 Test Gross profit increased to $16.8 million, representing 83.7...

-- Co-Diagnostics, Inc.  (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ COVID-19 Test Kit was used by Australian researchers to demonstrate rapidly deployable mobile molecular diagnostics support for remote locations, with the peer-reviewed results published in the Journal of Medical Microbiology. The study was performed using readily available open-source equipment and materials that could be successfully operated in regional clinical laboratories, many of which are not curr...

NA Proactive news snapshot: Snowline Gold, PharmaDrug, Fortitude Gold, Cloud Nine Web3 Technologies UPDATE … A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Snowline Gold Corp (CSE:SGD) has told shareholders that its Cynthia gold project in Yukon has both bulk tonnage and high-grade exploration potential. Located in the Selwyn Basin, Cynthia covers a four-square-kilometre area of gold mineralization along strike from a past-producing mine and within eight kilometres of a heavy equipment...

Co-Diagnostics says Logix Smart COVID-19 Test performance validated by Australian researchers in peer-reviewed publication A paper published in the Journal of Medical Microbiology utilizes the company's Logix Smart COVID-19 Test Kit in rapidly deployable mobile molecular diagnostics Co-Diagnostics CEO Dwight Egan said the results of the 'independent peer-reviewed paper further establishes the robustness, versatility, and quality of our Logix Smart COVID-19 diagnostic' Co-Diagnostics Inc (NASDAQ:CODX), a molecular diagnostics company with a patented platform for the development of ...

Share this article SALT LAKE CITY, Feb. 16, 2021 /PRNewswire/ -- Co-Diagnostics, Inc.  (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will be presenting on direct saliva testing for COVID-19 at the 28 th Annual International Molecular Medicine Tri-Conference, held virtually on February 16-18, 2021. Company representatives will introduce the Co-Diagnostics Logix Smart SARS-CoV-2 DS (Direct Saliva) kit, which the Company has submitted for Emergency Use Authorization (EUA) to the US Food and Drug...